Refine by:
-
Regulatory Comment on Medicaid
Regulatory comment to Secretary Becerra, offering strong support for Tennessee’s Medicaid demonstration waiver request to cover short-term, clinically appropriate care in IMDs for adults and children. -
Letter to Congressional Leadership on Medicare and Mental Health Funding
Letter urging congressional leaders to extend expiring Medicare funding for beneficiary low-income outreach and enrollment by State Health Insurance Assistance Programs (SHIPS), Area Agencies on Aging and local Benefits Enrollment Centers. -
Advocacy Resource on Mental Health Funding and Crisis Services
POLITICO ad coinciding with NAMI’s Executive Directors’ Leadership Exchange Hill Day, urging continued support and funding for mental health crisis response. -
Letter to CMS on Child and Adolescent Mental Health, Parity, and Medicaid
Letter asking CMS to consider the needs of children and youth as they finalize the tools for states to document compliance with Mental Health Parity and Addiction Equity Act (MHPAEA) requirements in Medicaid and the Children’s Health Insurance Program. -
Regulatory Comment to CMS on Medicaid and Parity
Regulatory comment to CMS in response to its draft guidance and templates on Mental Health Parity and Addiction Equity Act (MHPAEA) compliance in Medicaid and CHIP, expressing gratitude for the ongoing effort to improve care, and offering additional recommendations. -
Regulatory Comment to the FDA on Health Equity
Regulatory comment supporting the FDA’s proposed rule banning electrical stimulation devices, and urging the FDA to take all necessary steps to release the final rule as soon as possible. -
Letter to Congressional Committee Leadership on Research and Treatment Innovation and Mental Health Funding
Letter encouraging Congress to support the funding level proposed by the Senate Appropriations Committee for two NIH programs, the BRAIN Initiative and the All of Us Research Program, which would continue to make revolutionary advances that can improve brain and overall health outcomes. -
Letter to Congressional Leadership on Medicaid and Criminal Justice
Letter urging House and Senate leadership to pass the Reentry Act (H.R.2400/S.1165) and Due Process Continuity of Care Act (H.R.3074/S.971) before the end of the 118th Congress. -
Letter to Congressional Committee Leadership on Research and Treatment Innovation and Mental Health Funding
Letter urging Congress to finalize the Labor, Health and Human Services, Education, and Related Agencies (Labor-HHS) spending bill by the end of the calendar year with a robust investment in the NIH. -
Letter to Congressional Committee Leadership on Research and Treatment Innovation and Mental Health Funding
Letter requesting that Congress include the $5 million for the FDA’s Neurology Drug Program, as proposed by the Senate Appropriations Committee.